212 related articles for article (PubMed ID: 31254960)
1. Response heterogeneity to home-based restorative cognitive rehabilitation in multiple sclerosis: An exploratory study.
Fuchs TA; Ziccardi S; Dwyer MG; Charvet LE; Bartnik A; Campbell R; Escobar J; Hojnacki D; Kolb C; Oship D; Pol J; Shaw MT; Wojcik C; Yasin F; Weinstock-Guttman B; Zivadinov R; Benedict RHB
Mult Scler Relat Disord; 2019 Sep; 34():103-111. PubMed ID: 31254960
[TBL] [Abstract][Full Text] [Related]
2. Functional Connectivity and Structural Disruption in the Default-Mode Network Predicts Cognitive Rehabilitation Outcomes in Multiple Sclerosis.
Fuchs TA; Ziccardi S; Benedict RHB; Bartnik A; Kuceyeski A; Charvet LE; Oship D; Weinstock-Guttman B; Wojcik C; Hojnacki D; Kolb C; Escobar J; Campbell R; Tran HD; Bergsland N; Jakimovski D; Zivadinov R; Dwyer MG
J Neuroimaging; 2020 Jul; 30(4):523-530. PubMed ID: 32391981
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological management of multiple sclerosis: evaluation of a supervised and customized cognitive rehabilitation program for self-used at home (SEPIA): protocol for a randomized controlled trial.
Harand C; Daniel F; Mondou A; Chevanne D; Creveuil C; Defer G
Trials; 2019 Oct; 20(1):614. PubMed ID: 31665039
[TBL] [Abstract][Full Text] [Related]
4. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
[TBL] [Abstract][Full Text] [Related]
5. Trait Conscientiousness predicts rate of longitudinal SDMT decline in multiple sclerosis.
Fuchs TA; Wojcik C; Wilding GE; Pol J; Dwyer MG; Weinstock-Guttman B; Zivadinov R; Benedict RH
Mult Scler; 2020 Feb; 26(2):245-252. PubMed ID: 30615562
[TBL] [Abstract][Full Text] [Related]
6. Influence of personality on the relationship between gray matter volume and neuropsychiatric symptoms in multiple sclerosis.
Benedict RH; Schwartz CE; Duberstein P; Healy B; Hoogs M; Bergsland N; Dwyer MG; Weinstock-Guttman B; Zivadinov R
Psychosom Med; 2013 Apr; 75(3):253-61. PubMed ID: 23504242
[TBL] [Abstract][Full Text] [Related]
7. Traumatic hemorrhagic brain injury: impact of location and resorption on cognitive outcome.
Martin RM; Wright MJ; Lutkenhoff ES; Ellingson BM; Van Horn JD; Tubi M; Alger JR; McArthur DL; Vespa PM
J Neurosurg; 2017 Mar; 126(3):796-804. PubMed ID: 27231979
[TBL] [Abstract][Full Text] [Related]
8. A Randomised Controlled Trial of Efficacy of Cognitive Rehabilitation in Multiple Sclerosis: A Cognitive, Behavioural, and MRI Study.
Campbell J; Langdon D; Cercignani M; Rashid W
Neural Plast; 2016; 2016():4292585. PubMed ID: 28116167
[No Abstract] [Full Text] [Related]
9. Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis.
Feinstein A; Meza C; Stefan C; Staines RW
Brain; 2019 Sep; 142(9):2800-2812. PubMed ID: 31363742
[TBL] [Abstract][Full Text] [Related]
10. Brain volumetric correlates of remotely versus in-person administered symbol digit modalities test in multiple sclerosis.
Buyukturkoglu K; Dworkin JD; Leiva V; Provenzano FA; Guevara P; De Jager PL; Leavitt VM; Riley CS
Mult Scler Relat Disord; 2022 Dec; 68():104247. PubMed ID: 36274283
[TBL] [Abstract][Full Text] [Related]
11. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
López-Góngora M; Querol L; Escartín A
BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
[TBL] [Abstract][Full Text] [Related]
12. Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx).
Feinstein A; Amato MP; Brichetto G; Chataway J; Chiaravalloti N; Dalgas U; DeLuca J; Feys P; Filippi M; Freeman J; Meza C; Inglese M; Motl RW; Rocca MA; Sandroff BM; Salter A; Cutter G;
BMC Neurol; 2020 May; 20(1):204. PubMed ID: 32443981
[TBL] [Abstract][Full Text] [Related]
13. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
14. Multi-modal neuroimaging signatures predict cognitive decline in multiple sclerosis: A 5-year longitudinal study.
Al-Iedani O; Lea S; Alshehri A; Maltby VE; Saugbjerg B; Ramadan S; Lea R; Lechner-Scott J
Mult Scler Relat Disord; 2024 Jan; 81():105379. PubMed ID: 38103511
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a self-administered iPad
Hechenberger S; Helmlinger B; Tinauer C; Jauk E; Ropele S; Heschl B; Wurth S; Damulina A; Eppinger S; Demjaha R; Khalil M; Enzinger C; Pinter D
J Neurol; 2024 Jun; 271(6):3268-3278. PubMed ID: 38441609
[TBL] [Abstract][Full Text] [Related]
16. Feasibility study of a 10-week community-based program using the WalkWithMe application on physical activity, walking, fatigue and cognition in persons with Multiple Sclerosis.
Van Geel F; Geurts E; Abasıyanık Z; Coninx K; Feys P
Mult Scler Relat Disord; 2020 Jul; 42():102067. PubMed ID: 32371377
[TBL] [Abstract][Full Text] [Related]
17. Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial.
Feinstein A; Amato MP; Brichetto G; Chataway J; Chiaravalloti ND; Cutter G; Dalgas U; DeLuca J; Farrell R; Feys P; Filippi M; Freeman J; Inglese M; Meza C; Motl RW; Rocca MA; Sandroff BM; Salter A;
Lancet Neurol; 2023 Oct; 22(10):912-924. PubMed ID: 37739574
[TBL] [Abstract][Full Text] [Related]
18. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
Riccitelli GC; Pagani E; Rodegher M; Colombo B; Preziosa P; Falini A; Comi G; Filippi M; Rocca MA
Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009
[TBL] [Abstract][Full Text] [Related]
19. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
[TBL] [Abstract][Full Text] [Related]
20. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
